Kura Oncology (KURA) Invested Capital (2010 - 2026)
Kura Oncology (KURA) reported Invested Capital of $107.9 million for Q1 2026, down 70.55% year-over-year from $366.3 million in Q1 2025, and down 41.32% on a QoQ basis from $183.8 million in Q4 2025.
Kura Oncology (KURA) has 17 years of Invested Capital data on file, last reported at $107.9 million in Q1 2026.
- Quarterly Invested Capital fell 70.55% year-over-year to $107.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $107.9 million (down 70.55% YoY) and the FY2025 annual result came in at $183.8 million, down 55.84% from the prior year.
- Invested Capital fell to $107.9 million in Q1 2026 per KURA's latest filing, from $183.8 million in the prior quarter.
- Across five years, Invested Capital topped out at $505.1 million in Q1 2024 and bottomed at $107.9 million in Q1 2026.
- The 5-year median for Invested Capital is $419.6 million (2022), against an average of $380.9 million.
- The widest annual swing landed in 2024, when Invested Capital increased 27.81%; it then slumped 70.55% in 2026.
- Tracing KURA's Invested Capital over 5 years: stood at $420.3 million in 2022, then slipped by 5.47% to $397.3 million in 2023, then grew by 4.78% to $416.2 million in 2024, then plunged by 55.84% to $183.8 million in 2025, then slumped by 41.32% to $107.9 million in 2026.
- Per Business Quant, the three latest KURA Invested Capital figures stand at $107.9 million (Q1 2026), $183.8 million (Q4 2025), and $246.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 595,226.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 110.96 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 31.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Kura Oncology | 801.92 Mn | 801.92 Mn | 18.00 Mn | 107.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 107.88 Mn |
| Dec 31, 2025 | 183.84 Mn |
| Sep 30, 2025 | 246.88 Mn |
| Jun 30, 2025 | 308.60 Mn |
| Mar 31, 2025 | 366.33 Mn |
| Dec 31, 2024 | 416.25 Mn |
| Sep 30, 2024 | 425.49 Mn |
| Jun 30, 2024 | 466.92 Mn |
| Mar 31, 2024 | 505.08 Mn |
| Dec 31, 2023 | 397.27 Mn |
| Sep 30, 2023 | 429.94 Mn |
| Jun 30, 2023 | 459.68 Mn |
| Mar 31, 2023 | 395.18 Mn |
| Dec 31, 2022 | 420.28 Mn |
| Sep 30, 2022 | 419.62 Mn |
| Jun 30, 2022 | 449.49 Mn |
| Mar 31, 2022 | 476.25 Mn |
| Dec 31, 2021 | 506.61 Mn |
| Sep 30, 2021 | 533.76 Mn |
| Jun 30, 2021 | 558.55 Mn |
| Mar 31, 2021 | 588.99 Mn |
| Dec 31, 2020 | 618.16 Mn |
| Sep 30, 2020 | 309.00 Mn |
| Jun 30, 2020 | 324.12 Mn |
| Mar 31, 2020 | 204.20 Mn |
| Dec 31, 2019 | 219.03 Mn |
| Sep 30, 2019 | 233.58 Mn |
| Jun 30, 2019 | 246.58 Mn |
| Mar 31, 2019 | 149.57 Mn |
| Dec 31, 2018 | 160.99 Mn |
| Sep 30, 2018 | 177.44 Mn |
| Jun 30, 2018 | 115.21 Mn |
| Mar 31, 2018 | 127.09 Mn |
| Dec 31, 2017 | 81.40 Mn |
| Sep 30, 2017 | 90.22 Mn |
| Jun 30, 2017 | 44.14 Mn |
| Mar 31, 2017 | 50.24 Mn |
| Dec 31, 2016 | 56.88 Mn |
| Sep 30, 2016 | 63.67 Mn |
| Jun 30, 2016 | 70.04 Mn |
| Mar 31, 2016 | 76.07 Mn |
| Dec 31, 2015 | 82.34 Mn |
| Sep 30, 2015 | 38.02 Mn |
| Jun 30, 2015 | 43.32 Mn |
| Mar 31, 2015 | 48.89 Mn |
| Dec 31, 2014 | -3.43 Mn |
| Sep 30, 2014 | -143,038.00 |
| Jun 30, 2014 | -136,610.00 |
| Mar 31, 2014 | -129,723.00 |
| Dec 31, 2013 | -123,957.00 |
| Sep 30, 2013 | -114,207.00 |
| Jun 30, 2013 | -108,068.00 |
| Mar 31, 2013 | -101,319.00 |
| Dec 31, 2012 | -95,346.00 |
| Sep 30, 2012 | -85,684.00 |
| Jun 30, 2012 | -79,671.00 |
| Mar 31, 2012 | -73,403.00 |
| Dec 31, 2011 | -68,031.00 |
| Sep 30, 2011 | -59,147.00 |
| Jun 30, 2011 | -52,880.00 |
| Mar 31, 2011 | -68,031.00 |
| Dec 31, 2010 | -40,991.00 |